Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garrett

Showing results (11-20 of 330) with videos related to

Pageof 33
Sort By:
The Lancet. Oncology|May 31, 2026
The global cancer workforce crisis: a shared responsibility, a united frontJulie R Gralow, Douglas Pyle, Elizabeth Garrett-Mayer
Plos Medicine|March 29, 2007
How should treatment decisions be made for incapacitated patients, and why?David I Shalowitz, Elizabeth Garrett-Mayer, David Wendler
Chest|May 12, 2004
Molecular classification of lung cancer: a cross-platform comparison of gene expression data setsGiovanni Parmigiani, Elizabeth Garrett, Ramaswamy Anbazhagan, et al.
The American Journal of Hospice & Palliative Care|August 14, 2014
Barriers to employment of African American professionals in hospice: a qualitative study with African American social work studentsBridget Munoz, Elizabeth Garrett, Dona Reese, et al.
Archives of Internal Medicine|March 15, 2006
The accuracy of surrogate decision makers: a systematic reviewDavid I Shalowitz, Elizabeth Garrett-Mayer, David Wendler
Clinical Trials (London, England)|October 29, 2014
A likelihood-based approach for computing the operating characteristics of the 3+3 phase I clinical trial design with extensions to other A+B designsCody Chiuzan, Elizabeth Garrett-Mayer, Sharon D Yeatts
Archives of General Psychiatry|July 4, 2007
Social and communication development in toddlers with early and later diagnosis of autism spectrum disordersRebecca J Landa, Katherine C Holman, Elizabeth Garrett-Mayer
Statistics in Medicine|November 17, 2022
Explicit underdose control based on toxicity: Four points to considerPaul H Frankel, Elizabeth Garrett-Mayer, Mark D Krailo
Stroke|May 4, 2002
Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of agePaul Muntner, Elizabeth Garrett, Michael J Klag, et al.
Contemporary Clinical Trials|December 18, 2022
Quasi-partial order continual reassessment method: Applying toxicity scores to cancer dose-finding drug combination trialsNathaniel S O'Connell, Nolan A Wages, Elizabeth Garrett-Mayer
Pageof 33

Showing results (11-20 of 330) with videos related to

Sort By:
Pageof 33
The Lancet. Oncology|May 31, 2026
The global cancer workforce crisis: a shared responsibility, a united frontJulie R Gralow, Douglas Pyle, Elizabeth Garrett-Mayer
Plos Medicine|March 29, 2007
How should treatment decisions be made for incapacitated patients, and why?David I Shalowitz, Elizabeth Garrett-Mayer, David Wendler
Chest|May 12, 2004
Molecular classification of lung cancer: a cross-platform comparison of gene expression data setsGiovanni Parmigiani, Elizabeth Garrett, Ramaswamy Anbazhagan, et al.
The American Journal of Hospice & Palliative Care|August 14, 2014
Barriers to employment of African American professionals in hospice: a qualitative study with African American social work studentsBridget Munoz, Elizabeth Garrett, Dona Reese, et al.
Archives of Internal Medicine|March 15, 2006
The accuracy of surrogate decision makers: a systematic reviewDavid I Shalowitz, Elizabeth Garrett-Mayer, David Wendler
Clinical Trials (London, England)|October 29, 2014
A likelihood-based approach for computing the operating characteristics of the 3+3 phase I clinical trial design with extensions to other A+B designsCody Chiuzan, Elizabeth Garrett-Mayer, Sharon D Yeatts
Archives of General Psychiatry|July 4, 2007
Social and communication development in toddlers with early and later diagnosis of autism spectrum disordersRebecca J Landa, Katherine C Holman, Elizabeth Garrett-Mayer
Statistics in Medicine|November 17, 2022
Explicit underdose control based on toxicity: Four points to considerPaul H Frankel, Elizabeth Garrett-Mayer, Mark D Krailo
Stroke|May 4, 2002
Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of agePaul Muntner, Elizabeth Garrett, Michael J Klag, et al.
Contemporary Clinical Trials|December 18, 2022
Quasi-partial order continual reassessment method: Applying toxicity scores to cancer dose-finding drug combination trialsNathaniel S O'Connell, Nolan A Wages, Elizabeth Garrett-Mayer
Pageof 33